Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-concentration sufentanil target-controlled infusion in laparoscopic surgery
ChiCTR-TRC-13003631Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sufentanil (3 arms), sponsored by Peking University Third Hospital. Primary endpoints: Plasma sufentanil concentration and Hemodynamic change. Started Oct 2013; status: completed.
02
Drugs
sufentanil
Beyond the preview
Go deeper on ChiCTR-TRC-13003631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003631.